Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

Derma rollers show promise for skin improvement and drug delivery, but more research is needed on their safety and effectiveness.

PRP shows promise for skin rejuvenation but needs more research.

PRGF treatment safely and effectively helps hair loss.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

Using neurohormones to control keratin can lead to new skin disease treatments.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.

The study found that injecting spores directly into rabbit skin effectively caused fungal skin infections, with symptoms worsening over time.

Horse skin stem cells combined with platelet-rich plasma improve skin healing.

Modified KGF mRNA helps skin cells grow and move faster, which may improve wound healing.

Scientists found a new, less invasive way to get stem cells from horse hair for veterinary medicine.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Botulinum toxin type A reduces itch and inflammation from histamine and may help treat certain skin conditions and hair loss.

Advanced human skin models improve drug development and could replace animal testing.

The lowest effective dose of Botox for detrusor sphincter dyssynergia is between 75-100 units.

Combining platelet-rich plasma and minoxidil can effectively regrow hair in severe alopecia areata cases.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

Cannabinoids may help treat various skin conditions.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

A man's rash caused by Finasteride improved after stopping the drug and starting new treatments.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Dermal sheath cells can help grow new hair follicles and show promise in treating hair loss.

Science improves peace by advancing medical treatments, like laser therapies and non-invasive imaging.

Nanoparticles improve drug delivery and effectiveness in treating inflamed skin.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.